Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study (Q43750575)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study
scientific article

    Statements

    Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study (English)
    Reinhart K
    Menges T
    Gardlund B
    Harm Zwaveling J
    Smithes M
    Vincent JL
    Tellado JM
    Salgado-Remigio A
    Zimlichman R
    Withington S
    Tschaikowsky K
    Brase R
    Damas P
    Kupper H
    Kempeni J
    Eiselstein J
    1 April 2001
    765-769

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit